.jpeg)
Are there any domestic hospitals in Rasagiline?
In 2017, the original drug Rasagiline was approved by the National Medical Products Administration and was marketed in China for the symptom management of idiopathic Parkinson's disease. As the initial monotherapy and adjuvant therapy of levodopa, Rasagiline is a drug called a monoamine oxidase type B inhibitor. It works by increasing the amount of certain natural substances in the brain. After being launched in China, it has passed the relevant policies of the National Medical Insurance Bureau and entered the ranks of Class B medical insurance. The common name is rasagiline mesylate tablets. Specifications: The price of 1mg*14 tablets per box may be around 600 yuan. This drug may be sold in domestic pharmacies or hospitals.
[ 免责声明 ] 本页面内容来自公开渠道（如FDA官网、Drugs官网、原研药厂官网等），仅供持有医疗专业资质的人员用于医学药学研究参考，不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市，不适用于中国境内销售和使用。如需治疗，请咨询正规医疗机构。本站不提供药品销售或代购服务。
